title: Early clinical trials with colony-stimulating factors.
authors: Ludwig Institute for Cancer Research, P.O. Royal Melbourne Hospital, Victoria, Australia.
authors: G
authors: G
authors: Morstyn
authors: G J
authors: GJ
authors: Lieschke
authors: J
authors: J
authors: Cebon
authors: U
authors: U
authors: Dührsen
authors: J L
authors: JL
authors: Villeval
authors: W
authors: W
authors: Sheridan
authors: K
authors: K
authors: McGrath
authors: J E
authors: JE
authors: Layton
mesh_terms: D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D009503:Neutropenia / Q000517:prevention & control; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D003115:Colony-Stimulating Factors; D006133:Growth Substances; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor